Psychedelic drugs could be the answer for many mental health illnesses, such as depression and dementia
In a world of increasing mental-health crisis, in which, according to the the World Health Organization, depression took the toll over the leadership of disability worldwide, the need for substances that boost the quality of life is more and more intense.
More than 300 million people are currently affected by depression and anxiety disorders, as many drug groups are still considered to be taboos by the modern medicine.
Nevertheless, a recent study suggests that psychedelics could be the answer for countless chronic mental health problems, because they can transform the neuro-plasticity of the brain by rearranging hardwired neural patterns.
The research, published in the Journal of Psycho-pharmacology, indicates that LSD-assisted psychotherapy for people with high anxiety rates had optimum results in almost 70 per cent of subjects, and with no impairing side-effects. In order to clarify the exact effect psychedelic drugs can have on such patients, more clinical trial are needed. Unfortunately, the social prejudice against this type of therapy and strict anti-drug legislation severely impair scientists to find out more information on a potential cure.
As a growing number of people worldwide are beginning to search for help at unlicensed practitioners to take care of their mental health status, it is considered necessary to organized more events on the matter and fund more medical research into the mainstream, in order for the people to get the help they need to properly live their lives.